Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate

Summary

A prospective clinical, uncontrolled, open-label, explorative phase 2a trial on patients with histologically-confirmed superficial and nodular basal cell carcinoma (BCC). The study assesses tolerability and tumor clearance after laser-assisted topical delivery of topical ingenol mebutate.

Timeline

Start

2017-11-17

Primary completion

2018-05-18

Completion

2018-05-18

Drugs

Indications